Adial Pharmaceuticals, Inc.
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in phase 3 clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Charlottesville, Virginia. Show More...
-
Website http://www.adialpharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 0.69 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.17 -0.09 -0.21 -2.44 -0.87 -0.76 Dividends USD Payout Ratio % * Shares Mil 5.0 5.0 5.0 5.0 10.0 10.0 Book Value Per Share * USD 0.72 0.84 0.52 Free Cash Flow Per Share * USD -0.23 -0.64 Return on Assets % -378.31 -224.61 -491.42 -138.81 -90.95 Financial Leverage (Average) 1.33 1.06 1.08 1.07 Return on Equity % -501.39 -675.51 -148.36 -94.73 Return on Invested Capital % -502.16 -152.83 -608.16 -150.0 -96.01 Interest Coverage -42.58 -6.88 -8.97 Current Ratio 3.87 0.55 0.03 18.19 14.24 15.23 Quick Ratio 3.06 0.48 0.02 15.0 12.57 12.7 Debt/Equity